Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Heinz, A.
and
Jones, D. W.
2000.
Serotonin transporters in ecstasy users.
British Journal of Psychiatry,
Vol. 176,
Issue. 2,
p.
193.
Boot, Brandon P
McGregor, Iain S
and
Hall, Wayne
2000.
MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks.
The Lancet,
Vol. 355,
Issue. 9217,
p.
1818.
Burgess, C.
O’Donohoe, A.
and
Gill, M.
2000.
Agony and ecstasy: a review of MDMA effects and toxicity.
European Psychiatry,
Vol. 15,
Issue. 5,
p.
287.
Diksic, Mirko
and
Young, Simon N.
2001.
Study of the brain serotonergic system with labeled α‐methyl‐l‐tryptophan.
Journal of Neurochemistry,
Vol. 78,
Issue. 6,
p.
1185.
Parrott, A. C.
2001.
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 8,
p.
557.
MacInnes, N.
Handley, S. L.
and
Harding, G. F. A.
2001.
Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.
Journal of Psychopharmacology,
Vol. 15,
Issue. 3,
p.
181.
BUCHERT, R.
OBROCKI, J.
THOMASIUS, R.
VÄTERLEIN, O.
PETERSEN, K.
JENICKE, L.
BOHUSLAVIZKI, K. H.
and
CLAUSEN, M.
2001.
Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET.
Nuclear Medicine Communications,
Vol. 22,
Issue. 8,
p.
889.
O’Leary, Grace
Nargiso, Jessica
and
Weiss, Roger D.
2001.
3,4-methylenedioxymethamphetamine (mdma): A review.
Current Psychiatry Reports,
Vol. 3,
Issue. 6,
p.
477.
Reneman, Liesbeth
Booij, Jan
de Bruin, Kora
Reitsma, Johannes B
de Wolff, Frederik A
Gunning, W Boudewijn
den Heeten, Gerard J
and
van den Brink, Wim
2001.
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
The Lancet,
Vol. 358,
Issue. 9296,
p.
1864.
Ricaurte, George A.
and
McCann, Una D.
2001.
Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons.
Neurotoxicity Research,
Vol. 3,
Issue. 1,
p.
85.
Reneman, Liesbeth
Majoie, Charles B. L. M.
Habraken, Jan B. A.
and
den Heeten, Gerard J.
2001.
Effects of Ecstasy (MDMA) on the Brain in Abstinent Users: Initial Observations with Diffusion and Perfusion MR Imaging.
Radiology,
Vol. 220,
Issue. 3,
p.
611.
Fox, H. C.
Toplis, A. S.
Turner, J. J. D.
and
Parrott, A. C.
2001.
Auditory verbal learning in drug‐free Ecstasy polydrug users.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 8,
p.
613.
Heffernan, Thomas M.
Ling, Jonathon
and
Scholey, Andrew B.
2001.
Subjective ratings of prospective memory deficits in MDMA (‘ecstasy’) users.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 4,
p.
339.
Reneman, Liesbeth
Booij, Jan
Majoie, Charles B. L. M.
van den Brink, Wim
and
den Heeten, Gerard J.
2001.
Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach.
Human Psychopharmacology: Clinical and Experimental,
Vol. 16,
Issue. 8,
p.
579.
Teter, Christian J.
and
Guthrie, Sally K.
2001.
A Comprehensive Review of MDMA and GHB: Two Common Club Drugs.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 21,
Issue. 12,
p.
1486.
Patel, Jayendra K.
Wong, Eileen
and
Green, Alan I.
2001.
Vol. 24,
Issue. ,
p.
32.
Shankaran, Mahalakshmi
Yamamoto, Bryan K.
and
Gudelsky, Gary A.
2001.
Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
Synapse,
Vol. 40,
Issue. 1,
p.
55.
Morley, Kirsten C
Gallate, Jason E
Hunt, Glenn E
Mallet, Paul E
and
McGregor, Iain S
2001.
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”).
European Journal of Pharmacology,
Vol. 433,
Issue. 1,
p.
91.
Russell, B.R.
and
Laverty, R.
2001.
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
Pharmacology Biochemistry and Behavior,
Vol. 68,
Issue. 3,
p.
565.
Reneman, Liesbeth
De Bruin, Kora
Lavalaye, Jules
Gunning, W. Boudewijn
and
Booij, Jan
2001.
Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus.
Synapse,
Vol. 39,
Issue. 3,
p.
193.
eLetters
No eLetters have been published for this article.